Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

2020/03/11 by Lei Fang, George Karakiulakis, Michael Roth · 1 voice · 6 citations
Medicine · #COVID-19 Clinical Research Studies #Cardiovascular Disease and Adiposity #Heart Rate Variability and Autonomic Control

paper · pdf · doi:10.1016/s2213-2600(20)30116-8

openalex publication_date 2020/03/11 · crossref created 2020/03/11 · crossref issued 2020/04/01 · crossref published 2020/04/01 · crossref published-print 2020/04/01 · openalex created_date 2025/10/10 · crossref deposited 2025/11/01 · crossref indexed 2026/07/18 · openalex updated_date 2026/07/28

Citations

• Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
• Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
• Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
• Clinical Characteristics of Coronavirus Disease 2019 in China

Cited by

• Metformin in COVID-19: a magical role beyond the hyperglycemia
• Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults
• Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding
• Does Ibuprofen Worsen COVID-19?
• Diretriz Brasileira de Hipertensão Arterial – 2025
• The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments. v2

Discussions

• expression/activity https://doi.org/10.1016/s2213-2600(20)30116-8 2/ [bsky, 0 points, 1 comments]